Need pharma insights? Register for Evaluate Discovery
Menu
Menu
Are you exploring opportunities for alliances, in-licensing, or acquisition? Use Evaluate’s benchmarking and negotiation tools to understand the dealmaking landscape, with a depth of historical data for context. Easily compare metrics to validate decisions on partnerships, R&D strategies, and deal value. Use detailed data on comparable deals to structure and negotiate from a position of confidence.
Access insights that span therapy areas, mechanisms of action, and technologies. With a comprehensive perspective, you have the edge needed to secure higher deal values and drive R&D success.
Inform your strategy and allocation decisions with transparent data. Identify product acquisition opportunities and use insights from historical comparable deals to strengthen your negotiations and deal structures.
Understand how much your competitors paid when in-licensing or acquiring a particular pipeline asset, including financial details such as upfront payments, milestones, and royalties.
Effortlessly compare metrics and confirm internal insights. Create tailor-made intelligence with intuitive search and filtering that helps you make informed decisions about partnerships, deals, and drug development strategies.
Gain valuable insights during deal negotiations by identifying comparable deals and payment structures in relevant markets and therapy areas, and establish benchmarks accordingly.
Benchmark your forecasts by incorporating epidemiology data on the total potential and addressable market.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Find and validate pharma opportunities with a robust assessment of market fit, risk, uptake and sales forecasts, and more.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Build a better understanding of your growth drivers and product differentiators with a clear analysis of market dynamics, trends, unmet needs, and competitors.
Determine the true worth and potential of assets, score high-value opportunities, and make confident licensing or acquisition decisions.
Triangulate internal assumptions and power your allocation strategy with external benchmarking data across the R&D landscape.
Understand the context with data-driven insights
Kelly Chamberlain may not have been at the company very long, but that didn’t stop me swooping in to find out a little more about her. Kelly has joined Norstella,...
If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re...
There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by...
Evaluate’s annual World Preview report is a must-read for many in the pharma industry. Each year, we pull together some of our key pharma forecasts to build a picture of...
Can Forecasting Help Identify Market Opportunities for Pharmaceutical Companies? Forecasting serves to help pharmaceutical companies identify market opportunities, particularly when taking a sales-based approach and considering the wider competitive set....
Many pharmaceutical companies are harnessing digital solutions to elevate global forecasting. Digital tools, such as cloud-based, SaaS environments, are powering efficient, streamlined, and intelligent forecasting processes. But, for technological solutions...
